ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl
Equity
Direct
Sector - Healthcare
NAV: ₹ 15.1 as on 31-03-2023
Fund Performance
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl Performance as on (31-Mar-23)
About the Fund
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl is an equity fund. This fund was started on 12 July, 2018. The fund is managed by Dharmesh Kakkad, Sharmila D’mello. The fund could potentially beat inflation in the long-run.
Key parameters
1) ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl has a NAV of ₹15.08 as on 31-03-2023.
2) ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl has ₹2538 Cr worth of assets under management (AUM) as on 28-02-2023 and is more than category average.
3) The fund has an expense ratio 1.15 %.
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl Overview
 | 1.15% |
 Benchmark | S&P BSE Healthcare PR |
 | ₹2538 Cr |
 | 12 July, 2018 |
 | ₹5000/₹0 |
 Exit Load | 1% |
 | No Lock-in |
 TurnOver | 50.98% |
Fund Distribution as on (28-Feb-23)
Size breakup
Large cap
45%
Mid cap
29.3%
Small cap
22.7%
Sector Allocation
Health
96%
Financial Services
4%
Top Holdings of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl as on (31-Mar-23)
Equity Holdings31
See all
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl: Monthly Changes Updates
All changes are between Dec'22 and Feb'23
Fund Performance
- This fund’s returns stands at -1.72% whereas the fund’s underlying benchmark Nifty 500 returns stands at -2.22% as on Feb'23
- This fund outperformed Nifty 500 by 0.50% in Feb'23
AUM Change
- AUM of the fund stands at 2.5K Cr as of Feb'23
- AUM increased by 84.1 Cr between Feb'23 and Jan'23
Fund Portfolio Changes
Top Stocks bought last month
Cipla Ltd's allocation increased from 2.9% to 4.05%
Sun Pharmaceuticals Industries Ltd's allocation increased from 16.94% to 17.93%
Aurobindo Pharma Ltd's allocation increased from 3.16% to 3.93%
Top Stocks sold last month
Dr Reddy's Laboratories Ltd's allocation decreased from 8.26 % to 7.76 %
Lupin Ltd's allocation decreased from 5.09 % to 4.68 %
Sanofi India Ltd's allocation decreased from 3.96 % to 3.84 %
Mid Cap allocation has gone down from 29.5% to 29.3%
Large Cap allocation has gone down from 45.6% to 45%
Small Cap allocation has gone down from 23% to 22.7%
Cash allocation has gone up from 1.9% to 3%
Top 2 Sectors in February were Health, Financial Services
Feb'23
Health
96%
Financial Services
4%
Jan'23
Health
97%
Financial Services
3%
Gainers & Losers in ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl portfolio as on (28-Feb-23)
Top Growth Drivers | 1M Return |
|---|---|
 Aurobindo Pharma Ltd | 12.1% |
 Sanofi India Ltd | 7.3% |
 Alkem Laboratories Ltd | 4.8% |
Peer Analysis
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl Fund Manager
Dharmesh Kakkad
Fund Manager of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl, since 2 May 2020
Top funds managed
Sharmila D’mello
Fund Manager of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl, since 31 July 2022
Top funds managed
Fund Highlights
Very High Risk
Investors understand that their principal will be at Very High Risk
About the fund
This fund has delivered an average annual returns of 13.14% since inception which is less than its category average return of 13.95%
Fund Allocations
This fund has an allocation of 97.03% in Equity, 0% in Debt and 2.97% in Cash related instruments
AUM size ₹2538 Cr
This fund has AUM of ₹2538 Cr which is more than its category average of ₹ 1251 Cr
Expense Ratio 1.15%
This fund has an expense ratio of 1.15% which is less than its category average expense ratio of 1.56%
Frequently Asked Questions
The current NAV of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl is 14.89 as on 28-Mar-2023.
Existing (Absolute + CAGR)
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl | Absolute Returns | CAGR Returns |
1 Month Returns | 0.13% | 0.13% |
6 Month Returns | -1.72% | -1.72% |
1 Year Returns | -5.72% | -5.72% |
3 Years Returns | 87.67% | 23.35% |
5 Years Returns | 0% | 0% |
With INDmoney, the process of investing is very simple and involves zero commission.
- Click Buy on the fund name.
- Input the amount you are looking to invest.
- Select Lump Sum or SIP (Weekly, Monthly or Quarterly).
- Select your bank account and proceed with Payment.
1.15 as on March 2023
2538 Cr as on March 2023
Sun Pharmaceuticals Industries Ltd(16.4%),Dr Reddy's Laboratories Ltd(7.07%),Cipla Ltd(5.38%),Apollo Hospitals Enterprise Ltd(4.97%),Alkem Laboratories Ltd(4.7%) as on March 2023
Health(93.16%),Financial Services(3.86%),Cash Equivalent(2.97%) as on March 2023
The alpha ratio for the ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl for various period is as follows:
Fund Name | Alpha 1 Year | Alpha 3 Years | Alpha 5 Years |
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl | 2.94 | 0.83 | - |
As on March 2023
The alpha for ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl is calculated against S&P BSE Healthcare PR. Higher alpha indicates that this fund has generated extra returns compared to the benchmark index. An alpha of 1.0 means the fund has outperformed its benchmark index by 1%.
The Beta ratio for the ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl for various period is as follows:
Fund Name | Beta 1 Year | Beta 3 Years | Beta 5 Years |
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl | 0.82 | 0.96 | - |
As on March 2023
The Beta for ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl is calculated with S&P BSE Healthcare PR. Beta tells the volatility of the mutual fund relative to its benchmark. If the beta of a mutual fund is more than 1, then the mutual fund is more volatile than its benchmark. If beta is less than 1, then the mutual fund is less volatile than the benchmark.
The sharpe ratio for the ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl for various period is as follows:
Fund Name | Sharpe Ratio 1 Year | Sharpe Ratio 3 Years | Sharpe Ratio 5 Years |
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl | -0.56 | 0.65 | - |
As on March 2023
The sharpe ratio for ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl is calculated with S&P BSE Healthcare PR. Sharpe ratio tells risk-adjusted-returns of the mutual fund. The higher a fund's Sharpe ratio, the better a fund's returns have been relative to the risk it has taken on.
The standard deviation for the ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl for various period is as follows:
Fund Name | Standard Deviation 1 Year | Standard Deviation 3 Years | Standard Deviation 5 Years |
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl | 11.77 | 22.68 | - |
As on March 2023
Standard deviation tells the volatility of the returns of the mutual fund. The higher a fund's Standard deviation, the higher the volatility of the fund's returns.
Sortino ratio is 1.41 as on March 2023. Sortino ratio tells the downside risk-adjusted-returns of the mutual fund.
Information ratio is 0.05 as on March 2023. It tells the consistency of the fund in generating superior risk-adjusted performance
Dharmesh Kakkad,Sharmila D’mello are the fund managers of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl
The Exit load of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl is 1%